Search results
Finding the Best Psoriasis Treatment: How I Got Psoriasis Relief
Verywell Health via Yahoo News· 3 days agoTakeaway Humira was one of the first biologic medications approved for psoriatic arthritis in 2005...
How Long Does Carpal Tunnel Syndrome Usually Last? A Review By Doctors
MSN News· 6 days agoExpert opinion from Marcelle Freire Doctor of Medicine · 3 years of experience · Brazil Carpal...
Why Do I Have a Rash Between My Breasts?
Verywell Health via Yahoo News· 8 hours agoA rash between the breasts can develop for a variety of reasons, including heat, infection, or other more serious conditions like cancer. Here’s what to...
Treatment for Adult Diaper Rash
Verywell Health via Yahoo News· 6 days agoThe signs of a severe diaper rash or a mild rash that is getting worse include: Significant redness or discoloration, warm to the touch Raw...possible...
UCB Announces Publication in The Lancet of Phase 3 BIMZELX® (bimekizumab-bkzx) Trials in...
WPRI Providence· 1 day agoIn these studies, bimekizumab consistently demonstrated sustained improvements in clinical- as well as patient...
Ultravate side effects: What they are and how to manage them
Healthline· 5 days agoUltravate (halobetasol propionate) is a prescription drug that’s used to treat plaque psoriasis. Ultravate can cause side effects that range from mild to serious. Specifically ...
State board targets six prescription drugs to review for affordability for Marylanders
Maryland Matters via Yahoo News· 4 days agoThe board will seek public comments, additional information and data over the next 60 days to...
Stress can be "the triggering factor" for skin problems. Dermatologists share their advice.
CBS News· 3 days agoThere are many ways mental health can impact our physical health — but did you know stress can even...
TREMFYA® (guselkumab) QUASAR Maintenance Study in UC met its primary endpoint and all major...
FOX 23 News Albany· 4 days ago...20, 2024 /PRNewswire/ -- Johnson & Johnson today announced the first data from the Phase 3 QUASAR Maintenance Study (Abstract #759) that showed 50.0 percent (p<0.001) of patients with moderately to severely active ulcerative colitisa (UC) receiving subcutaneous (SC) TREMFYA® (guselkumab) 200 mg...
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
Morningstar· 4 days ago“We are proud to make SIMLANDI available in the U.S. to patients and providers,” said Thomas Rainey, Senior Vice President, U.S. Market...
